Stimulus-Funded CER: Few Awards Are For Drug Vs. Drug Studies
Executive Summary
Pitting one drug against another proved not to be a key focus of the comparative effectiveness research funding given from the $1.1 billion set aside for CER in the American Recovery and Reinvestment Act.